EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Physiological and immunological barriers in the lung

Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima iD

Seminars in Immunopathology · 2024-01 · 45 (4-6) · 533-547

DOI: 10.1007/s00281-024-01003-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 07.03.2024. Verfasst von Takahiro Kageyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba, 260-8670, Japan. t.kageyama@chiba…. Hauptthemen laut MEDLINE: Lung. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lungs serve as the primary organ for respiration, facilitating the vital exchange of gases with the bloodstream. Given their perpetual exposure to external particulates and pathogens, they possess intricate protective barriers. Cellular adhesion in the lungs is robustly maintained through tight junctions, adherens junctions, and desmosomes. Furthermore, the pulmonary system features a mucociliary clearance mechanism that synthesizes mucus and transports it to the outside. This mucus is enriched with chemical barriers like antimicrobial proteins and immunoglobulin A (IgA). Additionally, a complex immunological network comprising epithelial cells, neural cells, and immune cells plays a pivotal role in pulmonary defense. A comprehensive understanding of these protective systems offers valuable insights into potential pathologies and their therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LungHumansAnimalsMucociliary ClearanceRespiratory MucosaTight JunctionsCell AdhesionMucus

Stichwörter der Autor:innen

AsthmaImmunological barriersLungPhysiological barriers

Autor:innen und Institutionen

  • Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba, 260-8670, Japan. t.kageyama@chiba-u.jp.
  • Institute for Advanced Academic Research, Chiba University, Chiba, Japan. t.kageyama@chiba-u.jp.
  • Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba, 260-8670, Japan.
  • Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba, Japan.

ORCID-Profile: Hiroshi Nakajima

Zitieren

APA

Kageyama, T., Ito, T., Tanaka, S., & Nakajima, H. (2024). Physiological and immunological barriers in the lung. Seminars in Immunopathology, 45(4-6), 533-547. https://doi.org/10.1007/s00281-024-01003-y

Vancouver

Kageyama T, Ito T, Tanaka S, Nakajima H. Physiological and immunological barriers in the lung. Seminars in Immunopathology. 2024;45(4-6):533-547. doi:10.1007/s00281-024-01003-y

BibTeX
@article{Kageyama2024,
  author = {Kageyama, Takahiro and Ito, Takashi and Tanaka, Shigeru and Nakajima, Hiroshi},
  title = {Physiological and immunological barriers in the lung},
  journal = {Seminars in Immunopathology},
  year = {2024},
  volume = {45},
  number = {4-6},
  pages = {533--547},
  doi = {10.1007/s00281-024-01003-y}
}
Kostenlos starten →